Fig. 1From: Survival analysis after stereotactic ablative radiotherapy for early stage non-small cell lung cancer: a single-institution cohort studyConsort diagram. (In total, 238 patients with ES-NSCLC were recommended for SABR. Patients with PS > 2, operable or with history of cancer were excluded from the study. Finally 172 patients were analyzed)Back to article page